Incorporating innovative B-cell targeting therapeutics into a combined-modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B-cell lymphoma

被引：0
|
作者：
Chao, Yu-Ju [1 ]
Lee, Pei-Ing [2 ]
Yang, Tzu-Hsien [3 ]
Fang, Li-Hua [4 ]
Tsai, Yu-Chun [5 ]
Lee, Ming-Yuan [6 ]
Wang, Yun-Hsin [7 ]
Chen, Liuh-Yow [3 ]
Chen, Rong-Long [1 ]
机构：
[1] Koo Fdn Sun Yat Sen Canc Ctr, Dept Pediat Hematol & Oncol, Taipei, Taiwan
[2] Koo Fdn Sun Yat Sen Canc Ctr, Dept Nucl Med, Taipei, Taiwan
[3] Acad Sinica, Inst Mol Biol, Taipei, Taiwan
[4] Koo Fdn Sun Yat Sen Canc Ctr, Dept Pharm, Taipei, Taiwan
[5] Koo Fdn Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan
[6] Koo Fdn Sun Yat Sen Canc Ctr, Dept Pathol, Taipei, Taiwan
[7] Koo Fdn Sun Yat Sen Canc Ctr, Dept Mol Med, Taipei, Taiwan
来源：
PEDIATRIC BLOOD & CANCER | 2024年
关键词：
NON-HODGKIN-LYMPHOMA; CHILDREN; CHEMOTHERAPY; ADOLESCENTS; RITUXIMAB; THERAPY; SCT;
D O I：
10.1002/pbc.31289
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
    Othman, Tamer
    Frankel, Paul
    Allen, Pamela
    Popplewell, Leslie L.
    Shouse, Geoffrey
    Siddiqi, Tanya
    Danilov, Alexey V.
    Ruel, Nora
    Daniels, Shari
    Peters, Lacolle
    Khoo, Stella
    Rosen, Steven T.
    Sharon, Elad
    Villalona-Calero, Miguel
    Ruel, Christopher
    Tuscano, Joseph
    Herrera, Alex F.
    HAEMATOLOGICA, 2025, 110 (01) : 142 - 152
  • [42] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
    Aoki, T.
    Shimada, K.
    Suzuki, R.
    Izutsu, K.
    Tomita, A.
    Maeda, Y.
    Takizawa, J.
    Mitani, K.
    Igarashi, T.
    Sakai, K.
    Miyazaki, K.
    Mihara, K.
    Ohmachi, K.
    Nakamura, N.
    Takasaki, H.
    Kiyoi, H.
    Nakamura, S.
    Kinoshita, T.
    Ogura, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e372 - e372
  • [43] New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Schipani, Mattia
    Rivolta, Giulia Maria
    Margiotta-Casaluci, Gloria
    Mahmoud, Abdurraouf Mokhtar
    Al Essa, Wael
    Gaidano, Gianluca
    Bruna, Riccardo
    CANCERS, 2024, 16 (01)
  • [44] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    CANCERS, 2024, 16 (11)
  • [45] Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
    Sauter, Craig S.
    Matasar, Matthew J.
    Meikle, Jessica
    Schoder, Heiko
    Ulaner, Gary A.
    Migliacci, Jocelyn C.
    Hilden, Patrick
    Devlin, Sean M.
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    BLOOD, 2015, 125 (16) : 2579 - 2581
  • [46] Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma
    Paszkiewicz-Kozik, Ewa
    Michalski, Wojciech
    Taszner, Michal
    Mordak-Domagala, Monika
    Romejko-Jarosinska, Joanna
    Knopinska-Posluszny, Wanda
    Najda, Jacek
    Borawska, Anna
    Chelstowska, Monika
    Swierkowska, Monika
    Dabrowska-Iwanicka, Anna
    Malenda, Agata
    Druzd-Sitek, Agnieszka
    Konecki, Robert
    Kumiega, Beata
    Osowiecki, Michal
    Ostrowska, Beata
    Szpila, Tomasz
    Szymanski, Marcin
    Targonski, Lukasz
    Domanska-Czyz, Katarzyna
    Poplawska, Lidia
    Giebel, Sebastian
    Lange, Andrzej
    Pluta, Andrzej
    Zaucha, Jan Maciej
    Rymkiewicz, Grzegorz
    Walewski, Jan
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (01) : 73 - 81
  • [47] A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Cherng, Hua-Jay J.
    Chuang, Hubert H.
    Steiner, Raphael
    Fayad, Luis
    Strati, Paolo
    Nair, Ranjit
    Hagemeister, Fredrick
    Nastoupil, Loretta J.
    Lee, Hun Ju
    Neelapu, Sattva S.
    Flowers, Christopher R.
    Samaniego, Felipe
    Rodriguez, Maria
    Macapinlac, Homer A.
    Feng, Lei
    Westin, Jason
    LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 74 - 83
  • [48] The role of radiotherapy as salvage and/or consolidation treatment in relapsed/refractory and high-risk diffuse large B-cell lymphoma
    Grignano, Eric
    Laurent, Jeremy
    Deau, Benedicte
    Burroni, Barbara
    Bouscary, Didier
    Kirova, Youlia M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (02) : 150 - 159
  • [49] Salvage chemotherapy and autologous hematopoietic cell transplant in primary refractory diffuse large B-cell lymphoma: progress or better patient selection?
    Rosko, Ashley
    Lazarus, Hillard M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 756 - 757
  • [50] Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
    Appio, Lorena
    Landoni, Carlo
    La Targia, Maria
    Bertolli, Vanda
    Chiarucci, Martina
    Crovetti, Giovanni
    Vassenna, Elisabetta
    Serio, Giovanni
    Bregni, Marco
    CHEMOTHERAPY, 2017, 62 (03) : 187 - 191
12345